World's Most Advance Multi Cancer Detection test

Nearly 70% of cancers have no routine screening, leaving many undetected until symptoms appear. One Simple Blood Test. Insight Into 50+ Cancers.

160+ lab tests
Total each year
Whole body
Tested 2x per year
Powered by Independente Research

Detect Cancer Earlier. When It Matters Most.

A single blood test designed to identify multiple cancers often before symptoms appear.

We offer an advanced multi-cancer early detection blood test that looks for cancer-related signals in your blood helping identify some of the world’s deadliest cancers at their earliest, most treatable stages.

Unlike traditional screening programs that focus on just one cancer at a time, this test screens for multiple cancers in a single sample, including cancers that currently have no routine screening options.

Screen Smarter. Act Earlier. Protect Your Future.

Screen for Multiple Cancers with a Single Blood Test

Our testing screens for a unique “fingerprint” of many of the deadliest cancers, including those with no recommended screening tests today. The test looks for DNA in the blood sample shed by cancer cells.

Early detection can make all the difference. By identifying potential cancer signals before symptoms develop, this test empowers earlier clinical investigation, timely intervention, and greater peace of mind so you’re not waiting for something to feel wrong before taking action.

Today, doctors screen only 5 cancer types:

  • Colorectal
  • Lung (for those at risk)
  • Breast
  • Cervix
  • Prostate

Nearly 70% of cancers have no recommended screening tests

1 in 3 People Will Face Cancer And the Risk Accelerates After 50

  • More than 1 in 3 people will develop cancer in thier lifetime
  • Age is the strongest risk factor for cancer
  • People over 50 have up to 13× higher risk than those under 50
  • Risk increases with age, regardless of family history
  • Only 5–10% of cancers are inherited
  • Risk is further increased by: Smoking, Diabetes and Obesity (BMI > 30)

With our Early Multi Cancer Detection tests we do more

Our Early Multi-Cancer Detection Test screens for cancers across all major body systems—helping support earlier detection and more proactive health decisions.

  • Adrenal Cortical Carcinoma
  • Ampulla of Vater
  • Appendix, Carcinoma
  • Small Intestine, Bile Ducts, Distal
  • Bile Ducts, Intrahepatic
  • Bile Ducts, Perihilar
  • Bladder, Urinary
  • Bone
  • Breast
  • Colon, Anus and Rectum
  • Esophagus and Esophagogastric Junction
  • Gastrointestinal Stromal Tumor
  • Gestational Trophoblastic Neoplasms
  • Lung, Kidney, Liver and Stomach
  • Larynx and Oral Cavity
  • Leukemia
  • Lymphoma (Hodgkin and Non-Hodgkin)
  • Melanoma of the Skin
  • Merkel Cell Carcinoma
  • Mesothelioma, Malignant Pleural
  • Nasal Cavity and Paranasal Sinuses
  • Nasopharynx
  • Neuroendocrine Tumors of the Appendix
  • Neuroendocrine Tumors of the Pancreas
  • Oropharynx (HPV-Mediated, p16+)
  • Oropharynx (p16-) and Hypopharynx
  • Ovary, Fallopian Tube, and Primary Peritoneum
  • Pancreas, Exocrine
  • Penis, Prostate and Testis
  • Soft Tissue Sarcoma of the Head and Neck
  • Soft Tissue Sarcoma of the Retroperitoneum
  • Uterus, Carcinoma and Carcinosarcoma
  • Ureter, Renal Pelvis
  • Vagina, Vulva, Uterus, Cervix and Sarcoma
  • Plasma Cell Myeloma and Cell Disorders
  • Gallbladder
  • Neuroendocrine Tumors of the Colon and Rectum
  • Soft Tissue Sarcoma of the Abdomen and Thoracic Visceral Organs
  • Soft Tissue Sarcoma of the Trunk and Extremities
  • Soft Tissue Sarcoma Unusual Histologies and Sites

Advanced Cancer Detection You Can Trust

The Galleri test, offered by Cancer BioCare, is used in collaboration with leading cancer research institutes. It is supported by robust clinical evidence and has been evaluated in multiple clinical studies involving more than 20,000 participants.

The Galleri test collabtoration with leading cancer research institutes

How does the test Work ?

Revolutionizing Early Detection with DNA Insights

As cancers grow, they release fragments of DNA into the bloodstream-each carrying a unique "fingerprint" that reveals the presence of cancer. The Senior BioHealthcare test leverages this groundbreaking science to screen for many of the deadliest cancers long before symptoms appear, including those without existing recommended screening protocols.

By analyzing these DNA fragments, the Senior BioHealthcare test provides a predicted Cancer Signal Origin*, offering valuable insights to guide your healthcare provider in determining the next steps for accurate diagnosis and timely intervention.

"Because detecting cancer early can make all the difference."

Screen for Cancer Before Symptoms Appear

Advanced DNA-based screening for early cancer signals

CancerBioCare™ analyses hundreds of thousands of critical DNA sites to detect fragments of DNA released by cancer cells often before symptoms or scans can find a tumour. Because cancer can develop at any time, CancerBioCare™ provides a point-in-time molecular screen that looks for cancer-related DNA in your bloodstream at the moment of testing. This enables earlier awareness, earlier investigation, and more informed medical decisions.

Take more control and speak to our Biomedical healthcare team to learn more about our tests.

Frequently Asked Questions

Below you’ll find clear, straightforward answers to the most common questions about BioHealthcare Hub™ and KnowMyGut™ covering blood, gut, DNA, Cancer BioCare™, and pharmacogenomic testing. From choosing the right test and understanding how sample collection works, to receiving your results and the support available along the way, everything is explained clearly and calmly.

If you don’t find what you’re looking for, our team is always happy to help.

BioHealthcare Hub™ is a single, secure digital platform that brings together your blood, gut, DNA, and specialist health test results in one place.
It’s designed to help you understand how these areas connect, giving you a clearer, more complete picture of your health all through one secure dashboard.

Most providers focus on just one type of test. BioHealthcare Hub™ connects blood, gut, DNA, cancer screening, and pharmacogenomic testing into one platform, with results stored in a single dashboard and supported by biomedical and clinical expertise. This connected, supported approach is what sets us apart.

BioHealthcare Hub™ is for individuals who want clear health insight, a preventative and proactive approach, and human support alongside their results.
It is suitable for adults at all stages of life.

We offer a wide range of testing options, including:

  • Blood testing
  • Gut health testing (KnowMyGut™)
  • DNA & genetic testing
  • Pharmacogenomics
  • Cancer BioCare™ (multi-cancer early detection)
  • Specialist health programmes

Each test is clearly explained so you can choose confidently.

Yes. You may select individual tests or combine multiple tests. All results are stored together in your BioHealthcare Hub™ dashboard, making it easier to see connections and track progress over time.

If you’re unsure, you can review each test section in detail.
Our team is also available to provide guidance to help you choose the option most appropriate for your health goals.

Sample collection is designed to be simple, flexible, and convenient.
Depending on the test, samples may be collected:

  • At your home
  • At your place of work
  • At an approved healthcare or wellness location
  • Via a home collection kit sent to you
  • At one of our approved clinical locations
  • Clear instructions are always provided, and support is available if needed.

Yes. All sample collection methods follow strict clinical and hygiene standards, whether samples are self-collected, professionally collected, or taken at a clinical location.

Indicative turnaround times are as follows:

  • Blood tests: within 48 hours
  • EatIQ™ (IgG food response test): 5 days
  • Cancer BioCare™ (Galleri® multi-cancer test): 10 days
  • DNA tests, gut NGS sequencing & pharmacogenomics: 21 days

You will be notified as soon as results are available.

These tests use Next Generation Sequencing (NGS) and advanced genetic analysis.
They involve:

  • High-precision laboratory preparation
  • Deep sequencing of millions of DNA strands
  • Advanced bioinformatics analysis
  • Specialist clinical interpretation
  • The 21-day timeframe ensures accuracy, depth, and clinically meaningful results.

Cancer BioCare™ uses the Galleri® multi-cancer early detection test, which analyses DNA methylation patterns in the blood.
This advanced process screens for multiple cancer types and requires additional precision, validation, and quality controls to ensure reliable and responsible reporting.

All results are securely displayed in your BioHealthcare Hub™ dashboard.
You will also receive an email notification when results are released.

Once your results are available:

  • You receive an email notification
  • Results are presented clearly in your dashboard
  • A member of the BioHealthcare team may provide explanation and guidance
  • Where appropriate, next steps or follow-up options are discussed
  • Results remain available for long-term tracking and monitoring

You are supported beyond testing — not left alone with data.

Unfavourable results can feel concerning and that is completely normal.
If results highlight areas of concern:

  • They are explained calmly and clearly
  • Results are reviewed in context, not in isolation
  • Early insight often provides more options and control
  • Guidance on next steps may be offered
  • Ongoing monitoring and support remain available
  • Results are information designed to support informed decisions, not judgement.

When Cancer BioCare™ results are ready:

  • Results are made available in your dashboard
  • You receive an email notification
  • Where appropriate, a BioHealthcare Coach may contact you by phone to ensure results are not missed and to provide general, supportive guidance
  • All discussions are informational and supportive and do not replace medical advice.
  • Results can be shared with your healthcare providers with your consent.

Yes. BioHealthcare Hub™ is designed to work alongside your existing healthcare team, not replace them.
With your consent:

  • Results can be securely shared
  • Reports are structured for professional review
  • Conversations with your providers are better informed
  • You remain in full control of your data.

Yes. Your results remain stored in the BioHealthcare Hub™ dashboard, allowing you to track trends, monitor progress, and support long-term preventative health decisions.

Yes. Your data is protected using industry-standard security measures and handled in accordance with applicable data protection laws.

No. Your data is private and will never be shared without your explicit consent, except where required by law. .

From your first test through ongoing monitoring, you receive clear guidance, reassurance, and expert support at every stage of your journey.

You can contact our team through your BioHealthcare Hub™ account, or via the official email and phone details provided after purchase.

BioHealthcare Hub™ is designed to support clarity, confidence, and informed decision-making — working alongside qualified healthcare professionals, every step of the way.

BioMed InSights™ Global Research Drives our Services and Brands

Evidence-driven insights you can trust for a healthier future!

Powered by independent world class research

All BioHealthcare Hub™ medical protocols, testing pathways, and result interpretations are guided by the world’s leading medical research organisations and institutions. This evidence-based approach is translated into clear, practical understanding for our customers through BioHealth Insights our dedicated knowledge base designed to help you understand what your results mean and why they matter.

Copyright © 2025 All Right Reserved. A Bio Healthcare Networks Company.